Factors predicting mortality among patients with COVID-19 associated hospital acquired pneumonia: Insights from a tertiary care center
Hospital acquired pneumonia (HAP) is a severe and dangerous complication in patients admitted with COVID-19, causing significant morbidity and mortality globally. However, the early detection and subsequent management of high-risk cases may prevent disease progression and improve clinical outcomes....
Main Authors: | Nabila Kanwal, Humza Thobani, Ainan Arshad, Priya Ashok Kumar, Fatima Amjad, Safia Awan, Muhammad Irfan |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2022-12-01
|
Series: | Monaldi Archives for Chest Disease |
Subjects: | |
Online Access: | https://www.monaldi-archives.org/index.php/macd/article/view/2436 |
Similar Items
-
Hospital Acquired Pneumonia
by: Halis AKALIN, et al.
Published: (1999-12-01) -
Hospitalizations for Community-Acquired and Non-Ventilator-Associated Hospital-Acquired Pneumonia in Spain: Influence of the Presence of Bronchiectasis. A Retrospective Database Study
by: Gema Sanchez-Muñoz, et al.
Published: (2020-07-01) -
MODERN ANTIBACTERIAL THERAPY IN HOSPITAL-ACQUIRED PNEUMONIA
by: V. B. Beloborodov, et al.
Published: (2017-11-01) -
Frequency of Ventilator-associated Pneumonia With 3-day Versus 7-day Ventilator Circuit Changes
by: Ting-Chang Hsieh, et al.
Published: (2010-02-01) -
Hospital-acquired pneumonia in patients receiving immunosuppressive therapy
by: Ebru Çakır Edis, et al.
Published: (2010-03-01)